Ownership history in S.A. Mason LLC · 25 quarters on record
This page tracks every 13F SEC filing in which S.A. Mason LLC reported a position in AbbVie Inc (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 12,042 | -146 | -1.2% | 1.09% | $2.8M | $226.67 |
| 2025 Q3 | REDUCED | 12,188 | -99 | -0.8% | 1.25% | $2.8M | $228.05 |
| 2025 Q2 | REDUCED | 12,287 | -2 | -0.0% | 1.10% | $2.3M | $181.25 |
| 2025 Q1 | REDUCED | 12,289 | -456 | -3.6% | 1.36% | $2.6M | $202.72 |
| 2024 Q4 | ADDED | 12,745 | +104 | +0.8% | 1.19% | $2.3M | $170.33 |
| 2024 Q3 | ADDED | 12,641 | +18 | +0.1% | 1.32% | $2.5M | $187.79 |
| 2024 Q2 | ADDED | 12,623 | +336 | +2.7% | 1.23% | $2.2M | $161.62 |
| 2024 Q1 | ADDED | 12,287 | +20 | +0.2% | 1.34% | $2.2M | $170.00 |
| 2023 Q4 | REDUCED | 12,267 | -83 | -0.7% | 1.27% | $1.9M | $143.30 |
| 2023 Q3 | REDUCED | 12,350 | -548 | -4.2% | 1.33% | $1.8M | $136.47 |
As of 2025 Q4 — sorted by position size